Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Weight Gain × empagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3 Cardiotoxicity 2 Breast Neoplasms 2 Weight Gain 1 Renal Insufficiency, Chronic 1 Neoplasms 1 Kidney Neoplasms 1 Heart Failure 1 Carcinoma, Renal Cell 1

Interventions

Metformin 2 empagliflozin 1 Weights and Measures 1 Tablets 1 Sucrose 1 Secondary Prevention 1 Exercise 1 Cognitive Behavioral Therapy 1 Aspartame 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

SINA Health Education and Welfare Trust

Phase 2/3 Completed

Polycystic Ovary Syndrome, Weight Gain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡